Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis.
Nanoscale. 2024 Apr 18;16(15):7515-7531. doi: 10.1039/d3nr05351b.
Nanoscale. 2024.
PMID: 38498071
Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
Ortega MC, Lebrón-Galán R, Machín-Díaz I, Naughton M, Pérez-Molina I, García-Arocha J, Garcia-Dominguez JM, Goicoechea-Briceño H, Vila-Del Sol V, Quintanero-Casero V, García-Montero R, Galán V, Calahorra L, Camacho-Toledano C, Martínez-Ginés ML, Fitzgerald DC, Clemente D.
Ortega MC, et al. Among authors: machin diaz i.
Acta Neuropathol. 2023 Aug;146(2):263-282. doi: 10.1007/s00401-023-02593-x. Epub 2023 May 27.
Acta Neuropathol. 2023.
PMID: 37243699
Free PMC article.
Item in Clipboard
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
Camacho-Toledano C, Machín-Díaz I, Calahorra L, Cabañas-Cotillas M, Otaegui D, Castillo-Triviño T, Villar LM, Costa-Frossard L, Comabella M, Midaglia L, García-Domínguez JM, García-Arocha J, Ortega MC, Clemente D.
Camacho-Toledano C, et al. Among authors: machin diaz i.
J Neuroinflammation. 2022 Nov 19;19(1):277. doi: 10.1186/s12974-022-02635-3.
J Neuroinflammation. 2022.
PMID: 36403026
Free PMC article.
Item in Clipboard
Functional Heterogeneity of Mouse and Human Brain OPCs: Relevance for Preclinical Studies in Multiple Sclerosis.
Bribián A, Medina-Rodríguez EM, Josa-Prado F, García-Álvarez I, Machín-Díaz I, Esteban PF, Murcia-Belmonte V, Vega-Zelaya L, Pastor J, Garrido L, de Castro F.
Bribián A, et al. Among authors: machin diaz i.
J Clin Med. 2020 Jun 2;9(6):1681. doi: 10.3390/jcm9061681.
J Clin Med. 2020.
PMID: 32498223
Free PMC article.
Item in Clipboard
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.
Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martínez-Banaclocha H, Midaglia L, Sarró E, Machín-Díaz I, Villar LM, Triviño JC, Oliver-Martos B, Parladé LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martínez-Ginés ML, Tejeda-Velarde A, Fissolo N, Castilló J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lünemann JD, Espejo C, Montalban X, Comabella M.
Malhotra S, et al. Among authors: machin diaz i.
Brain. 2020 May 1;143(5):1414-1430. doi: 10.1093/brain/awaa084.
Brain. 2020.
PMID: 32282893
Free article.
Item in Clipboard
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
Melero-Jerez C, Alonso-Gómez A, Moñivas E, Lebrón-Galán R, Machín-Díaz I, de Castro F, Clemente D.
Melero-Jerez C, et al. Among authors: machin diaz i.
Neurobiol Dis. 2020 Jul;140:104869. doi: 10.1016/j.nbd.2020.104869. Epub 2020 Apr 9.
Neurobiol Dis. 2020.
PMID: 32278882
Free article.
Item in Clipboard
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
Melero-Jerez C, Suardíaz M, Lebrón-Galán R, Marín-Bañasco C, Oliver-Martos B, Machín-Díaz I, Fernández Ó, de Castro F, Clemente D.
Melero-Jerez C, et al. Among authors: machin diaz i.
Neurobiol Dis. 2019 Jul;127:13-31. doi: 10.1016/j.nbd.2019.02.014. Epub 2019 Feb 21.
Neurobiol Dis. 2019.
PMID: 30798007
Free article.
Item in Clipboard
Cite
Cite